Assignee
IMMUNOVIA AB
SE·5 granted patents·24 pending applications·3 citations·filing 2013–2022
Top patents by PatentIndex Score
29 records- 0183US11320436B2Methods, arrays and uses thereofIMMUNOVIA AB·Filed 2021·Granted May 3, 2022·3 cites·18 claims
- 0269US2021356478A1Method, array and use for determining the presence of pancreatic cancerIMMUNOVIA AB·Filed 2021·Application pending·0 cites
- 0369US2022390452A1Method of diagnosing or prognosing epithelial ovarian cancerIMMUNOVIA AB·Filed 2022·Application pending·0 cites
- 0468US11525832B2Protein signature/markers for the detection of adenocarcinomaIMMUNOVIA AB·Filed 2019·Granted Dec 13, 2022·0 cites·9 claims
- 0568US2020088742A1Method, array and use for determining the presence of pancreatic cancerIMMUNOVIA AB·Filed 2019·Application pending·0 cites
- 0666US2022214344A1Method, array and use thereofIMMUNOVIA AB·Filed 2022·Application pending·0 cites
- 0762US2022206004A1Method, array and use thereofIMMUNOVIA AB·Filed 2021·Application pending·0 cites
- 0860US2023074480A1Biomarker signatures of systemic lupus erythematosus and uses thereofIMMUNOVIA AB·Filed 2022·Application pending·0 cites
- 0960US2018136231A1Method, Array and Use for Determining the Presence of Pancreatic CancerIMMUNOVIA AB·Filed 2017·Application pending·0 cites
- 1060US2023063017A1Biomarker signatures of systemic lupus erythematosus and uses thereofIMMUNOVIA AB·Filed 2022·Application pending·0 cites
- 1157US2019018016A1Method of diagnosing or prognosing epithelial ovarian cancerIMMUNOVIA AB·Filed 2018·Application pending·0 cites
- 1257US2019128891A1Method, array and use thereofIMMUNOVIA AB·Filed 2018·Application pending·0 cites
- 1356US10859572B2Biomarker signatures and uses thereofIMMUNOVIA AB·Filed 2018·Granted Dec 8, 2020·0 cites·9 claims
- 1456US2023296608A1Methods, arrays and uses thereofIMMUNOVIA AB·Filed 2021·Application pending·0 cites
- 1556US2017307620A1Protein signature/markers for the detection of adenocarcinomaIMMUNOVIA AB·Filed 2017·Application pending·0 cites
- 1653US10564163B2Method, array and use thereofIMMUNOVIA AB·Filed 2018·Granted Feb 18, 2020·0 cites·18 claims
- 1753US2016252513A1Method, array and use thereofIMMUNOVIA AB·Filed 2014·Application pending·0 cites
- 1850US2016047815A1Method of diagnosing or prognosing epithelial ovarian cancerIMMUNOVIA AB·Filed 2015·Application pending·0 cites
- 1950US2018284120A1Methods for determining a breast cancer-associated disease state and arrays for use in the methodsIMMUNOVIA AB·Filed 2017·Application pending·0 cites
- 2047US2015057177A1Methods for determining a breast cancer-associated disease state and arrays for use in the methodsIMMUNOVIA AB·Filed 2013·Application pending·0 cites
- 2146US10048265B2Methods and arrays for use in the sameIMMUNOVIA AB·Filed 2014·Granted Aug 14, 2018·0 cites·25 claims
- 2245US2020041504A1Biomarker signatures of systemic lupus erythematosus and uses thereofIMMUNOVIA AB·Filed 2017·Application pending·0 cites
- 2345US2020057061A1Biomarker signatures of systemic lupus erythematosus and uses thereofIMMUNOVIA AB·Filed 2017·Application pending·0 cites
- 2439US2021181195A1Methods, conjugates and systemsIMMUNOVIA AB·Filed 2019·Application pending·0 cites
- 2538US2020011872A1Method, array and use thereofIMMUNOVIA AB·Filed 2017·Application pending·0 cites
- 2634US2022163524A1Methods, arrays and uses thereof for diagnosing or detecting an autoimmune diseaseIMMUNOVIA AB·Filed 2020·Application pending·0 cites
- 2733US2019382849A1Methods, arrays and uses thereofIMMUNOVIA AB·Filed 2018·Application pending·0 cites
- 2832US2021325395A1Method, array and use thereofIMMUNOVIA AB·Filed 2016·Application pending·0 cites
- 2929US2017192004A1Methods and Arrays for Use in the SameIMMUNOVIA AB·Filed 2015·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →